Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

High-throughput microsphiltration to assess red blood cell deformability and screen for malaria transmission-blocking drugs.

Duez J, Carucci M, Garcia-Barbazan I, Corral M, Perez O, Presa JL, Henry B, Roussel C, Ndour PA, Rosa NB, Sanz L, Gamo FJ, Buffet P.

Nat Protoc. 2018 Jun;13(6):1362-1376. doi: 10.1038/nprot.2018.035. Epub 2018 May 24.

PMID:
29844524
2.

Spherocytic shift of red blood cells during storage provides a quantitative whole cell-based marker of the storage lesion.

Roussel C, Dussiot M, Marin M, Morel A, Ndour PA, Duez J, Le Van Kim C, Hermine O, Colin Y, Buffet PA, Amireault P.

Transfusion. 2017 Apr;57(4):1007-1018. doi: 10.1111/trf.14015. Epub 2017 Feb 1.

PMID:
28150311
3.

Plasmodium falciparum STEVOR phosphorylation regulates host erythrocyte deformability enabling malaria parasite transmission.

Naissant B, Dupuy F, Duffier Y, Lorthiois A, Duez J, Scholz J, Buffet P, Merckx A, Bachmann A, Lavazec C.

Blood. 2016 Jun 16;127(24):e42-53. doi: 10.1182/blood-2016-01-690776. Epub 2016 May 2.

PMID:
27136945
4.

Mechanical clearance of red blood cells by the human spleen: Potential therapeutic applications of a biomimetic RBC filtration method.

Duez J, Holleran JP, Ndour PA, Pionneau C, Diakité S, Roussel C, Dussiot M, Amireault P, Avery VM, Buffet PA.

Transfus Clin Biol. 2015 Aug;22(3):151-7. doi: 10.1016/j.tracli.2015.05.004. Epub 2015 Jun 29. Review.

PMID:
26138907
5.

Splenic retention of Plasmodium falciparum gametocytes to block the transmission of malaria.

Duez J, Holleran JP, Ndour PA, Loganathan S, Amireault P, Français O, El Nemer W, Le Pioufle B, Amado IF, Garcia S, Chartrel N, Le Van Kim C, Lavazec C, Avery VM, Buffet PA.

Antimicrob Agents Chemother. 2015 Jul;59(7):4206-14. doi: 10.1128/AAC.05030-14. Epub 2015 May 4.

6.

Listeria phage and phage tail induction triggered by components of bacterial growth media (phosphate, LiCl, nalidixic acid, and acriflavine).

Lemaître JP, Duroux A, Pimpie R, Duez JM, Milat ML.

Appl Environ Microbiol. 2015 Mar;81(6):2117-24. doi: 10.1128/AEM.03235-14. Epub 2015 Jan 16.

7.

[Comments on the article of S. Vedy (Microbiology method validation: illustration with Bact'Alert 3D)].

Duez JM, Sixt N, Péchinot A.

Ann Biol Clin (Paris). 2014 Mar-Apr;72(2):255-6. doi: 10.1684/abc.2014.0947. French. No abstract available.

8.

First description of an RND-type multidrug efflux pump in Achromobacter xylosoxidans, AxyABM.

Bador J, Amoureux L, Duez JM, Drabowicz A, Siebor E, Llanes C, Neuwirth C.

Antimicrob Agents Chemother. 2011 Oct;55(10):4912-4. doi: 10.1128/AAC.00341-11. Epub 2011 Aug 1.

9.

A case of meningitis due to Achromobacter xylosoxidans denitrificans 60 years after a cranial trauma.

Manckoundia P, Mazen E, Coste AS, Somana S, Marilier S, Duez JM, Camus A, Popitean L, Bador J, Pfitzenmeyer P.

Med Sci Monit. 2011 Jun;17(6):CS63-5.

10.

In vitro synergistic activity of combined piperacillin and tobramycin against clinical strains of Achromobacter xylosoxidans.

Duez JM, Hadjait-Savioz M, Siebor E, Astruc K, Bador J, Péchinot A, Sixt N, Huet F, Neuwirth C.

J Chemother. 2010 Apr;22(2):139-41. No abstract available.

PMID:
20435577
11.

In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model.

Duez JM, Adochitei A, Péchinot A, Siebor E, Sixt N, Neuwirth C.

J Chemother. 2008 Dec;20(6):684-9.

PMID:
19129064
12.

Influenza virus infection: don't forget the role of the mucociliary system!

Duez JM, Sixt N, Péchinot A.

J Antimicrob Chemother. 2009 Feb;63(2):421-2. doi: 10.1093/jac/dkn468. Epub 2008 Nov 19. No abstract available.

PMID:
19022776
13.

Sudden onset of pseudotuberculosis in humans, France, 2004-05.

Vincent P, Leclercq A, Martin L; Yersinia Surveillance Network, Duez JM, Simonet M, Carniel E.

Emerg Infect Dis. 2008 Jul;14(7):1119-22. doi: 10.3201/eid1407.071339.

14.

Presumed pseudobacteremia outbreak resulting from contamination of proportional disinfectant dispenser.

Siebor E, Llanes C, Lafon I, Ogier-Desserrey A, Duez JM, Pechinot A, Caillot D, Grandjean M, Sixt N, Neuwirth C.

Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):195-8.

PMID:
17393202
15.

VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France.

Neuwirth C, Freby C, Ogier-Desserrey A, Perez-Martin S, Houzel A, Péchinot A, Duez JM, Huet F, Siebor E.

Emerg Infect Dis. 2006 Nov;12(11):1737-9. No abstract available.

16.
17.

One new LEN enzyme and two new OKP enzymes in Klebsiella pneumoniae clinical isolates and proposed nomenclature for chromosomal beta-lactamases of this species.

Siebor E, Péchinot A, Duez JM, Neuwirth C.

Antimicrob Agents Chemother. 2005 Jul;49(7):3097-8. No abstract available.

18.

Survey of Enterobacteriaceae producing extended-spectrum beta-lactamases in a Slovak hospital: dominance of SHV-2a and characterization of TEM-132.

Zarnayová M, Siebor E, Péchinot A, Duez JM, Bujdáková H, Labia R, Neuwirth C.

Antimicrob Agents Chemother. 2005 Jul;49(7):3066-9.

19.

Could an effervescent tablet, prepared with contaminated [correction of contamined] water, create an aerosol containing Legionella?

Belpois Duchamp C, Le Coq M, Bergeal E, Duez JM, Aho LS.

J Hosp Infect. 2002 May;51(1):77. No abstract available.

PMID:
12009829
20.

TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.

Neuwirth C, Madec S, Siebor E, Pechinot A, Duez JM, Pruneaux M, Fouchereau-Peron M, Kazmierczak A, Labia R.

Antimicrob Agents Chemother. 2001 Dec;45(12):3591-4.

21.

Evidence of in vivo transfer of a plasmid encoding the extended-spectrum beta-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae.

Neuwirth C, Siebor E, Pechinot A, Duez JM, Pruneaux M, Garel F, Kazmierczak A, Labia R.

J Clin Microbiol. 2001 May;39(5):1985-8.

22.

[Lung disease due to Mycobacterium xenopi excluding AIDS. Apropos of 8 cases].

Froidure M, Massin F, Duez JM, Baudouin N, Camus P, Jeannin L.

Rev Mal Respir. 2000 Apr;17(2):481-7. French.

PMID:
10859767
24.

Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humans.

Péchinot A, Neuwirth C, Bryskier A, Duez JM, Kazmierczak A.

J Antimicrob Chemother. 1997 Feb;39(2):157-62.

PMID:
9069535
25.

Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.

Neuwirth C, Siébor E, Duez JM, Péchinot A, Kazmierczak A.

J Antimicrob Chemother. 1995 Aug;36(2):335-42.

PMID:
8522463
26.

[In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin].

Duez JM, Siebor E, Pechinot A, Cordin X, Chamard-Neuwirth C, Kazmierczak A.

Pathol Biol (Paris). 1995 Mar;43(3):208-14. French.

PMID:
7675548
27.

Recurrent pneumonia due to rifampicin-resistant Rhodococcus equi in a patient infected with HIV.

Nordmann P, Chavanet P, Caillon J, Duez JM, Portier H.

J Infect. 1992 Jan;24(1):104-7. No abstract available.

PMID:
1548410
28.

[Uptake of ofloxacin by Escherichia coli].

Péchinot A, Duez JM, Siebor E, Mattioni D, Kazmierczak A.

Pathol Biol (Paris). 1991 May;39(5):410-9. French.

PMID:
1881671
29.

[Comparative study of the antibacterial activity of cefpodoxime against enterobacteria producing beta lactamases].

Siebor E, Cordin X, Delpech N, Duez JM, Kazmierczak A.

Pathol Biol (Paris). 1990 May;38(5):331-5. French.

PMID:
2367149
30.

[Nosocomial Staphylococcus epidermidis and Staphylococcus aureus septicemias in neonates].

Gouyon JB, François C, Semama D, Sandre D, Duez JM, Portier H.

Ann Pediatr (Paris). 1990 Jan;37(1):21-5. French.

PMID:
2316958
31.

Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.

Kazmierczak A, Cordin X, Duez JM, Siebor E, Pechinot A, Sirot J.

J Int Med Res. 1990;18 Suppl 4:67D-77D.

PMID:
2282971
32.

[Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].

Duez JM, Péchinot A, Siébor E, Cordin X, Kazmierczak A.

Pathol Biol (Paris). 1989 Apr;37(4):263-8. French.

PMID:
2543946
33.

[Treatment with a cefotaxime-fosfomycin combination of staphylococcal or enterobacterial meningitis in adults].

Portier H, Armengaud M, Becq-Giraudon B, Bousser J, Desbordes JM, Duez JM, Kazmierczak A, Korinek AM, Laisne MJ, Pangon B, et al.

Presse Med. 1987 Dec 16;16(43):2161-6. French.

PMID:
2963304
34.

Biliary tract excretion of ofloxacin in man.

Kazmierczak A, Pechinot A, Duez JM, Haas O, Favre JP.

Drugs. 1987;34 Suppl 1:39-43.

PMID:
3481327
35.

[Principles of antibiotic therapy in primary prevention of postoperative pulmonary infections].

Freysz M, Duez JM, Dupont G, Beal JL, Juniot A, Wilkening M.

Cah Anesthesiol. 1986 Dec;34(8):697-701. Review. French. No abstract available.

PMID:
3548921
36.

In vitro bactericidal activity of sulbactam plus ampicillin against methicillin-resistant Staphylococcus aureus.

Kazmierczak A, Duez JM, Pechinot A, Nordmann P, Labia R.

Rev Infect Dis. 1986 Nov-Dec;8 Suppl 5:S549-54.

PMID:
3026003
37.

[Inhibition of cephalosporinase of enterobacteria by ceftriaxone].

Péchinot A, Duez JM, Nordmann P, Kazmierczak A, Labia R.

Pathol Biol (Paris). 1986 May;34(5):399-403. French.

PMID:
3534712
38.

[Fosfomycin-cefotaxime combination in severe staphylococcal infections in newborn infants].

Gouyon JB, Duez JM, Portier H, Brichon P, Kohli E, Alison M.

Presse Med. 1985 Dec 7;14(42):2135-8. French.

PMID:
2935798
39.

[Bacteriologic monitoring of bronchial secretions in surgical intensive care].

Duez JM, Freysz M, Kohli E, Minello C, Wilkening M, Kazmierczak A.

Pathol Biol (Paris). 1985 May;33(5):440-3. French.

PMID:
3929220
40.
41.

Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections.

Portier H, Kazmierczak A, Lucht F, Tremeaux JC, Chavanet P, Duez JM.

Infection. 1985;13 Suppl 1:S123-8.

PMID:
3850854
42.

Treatment of severe staphylococcal infections with cefotaxime and fosfomycin in combination.

Portier H, Tremeaux JC, Chavanet P, Gouyon JB, Duez JM, Kazmierczak A.

J Antimicrob Chemother. 1984 Sep;14 Suppl B:277-84.

PMID:
6094452
43.

[HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime].

Pechinot A, Duez JM, Bryskier A, Labia R, Kazmierczak A.

Pathol Biol (Paris). 1984 May;32(5):386-8. French.

PMID:
6330649
44.

[Fatal course of Corynebacterium JK group pneumopathy in bone marrow aplasia].

Janin-Manificat L, Caillot D, Guy H, Duez JM, Riou JY, Cortet P.

Presse Med. 1983 Nov 5;12(39):2466. French. No abstract available.

PMID:
6227900
45.

[In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].

Kazmierczak A, Pechinot A, Duez JM, Kohli E, Tremeaux JC.

Sem Hop. 1983 Jun 30;59(26):1953-7. French.

PMID:
6310785
46.

[Combination between fosfomycin and oxacillin or cefotaxime against methicillin-resistant Staphylococci and Enterococci].

Duez JM, Kohli E, Pechinot A, Tremeaux JC, Kazmierczak A.

Pathol Biol (Paris). 1983 Jun;31(6):515-8. French.

PMID:
6308543
47.

[Importance of the cefotaxime-fosfomycin combination. Apropos of a case of meningitis due to heterogeneously resistant Staphylococcus aureus].

Tremeaux JC, Duez JM, Pechinot A, Sautreaux JL, Thierry A, Kazmierczak A.

Agressologie. 1983 Apr;24(4):169-71. French. No abstract available.

PMID:
6314832

Supplemental Content

Support Center